Favorable safety profile of ixekizumab: results from 11 moderate-to-severe psoriasis and 3 psoriatic arthritis clinical trials / Gottlieb A. ... [et al.]. Dermatológia pre prax Roč. 12, č. 3 (2018), s. 147